# Clinical Trial Budget and Financial Management Plan Template

## Document Control

| Document Information | Details |
|---------------------|---------|
| Document Title | Clinical Trial Budget and Financial Management Plan |
| Protocol Number | [Protocol Number] |
| Study Title | [Study Title] |
| Version | 1.0 |
| Date | [Date] |
| Prepared By | [Name and Title] |
| Reviewed By | [Name and Title] |
| Approved By | [Name and Title] |

### Document History

| Version | Date | Description of Changes | Author |
|---------|------|------------------------|--------|
| 1.0 | [Date] | Initial version | [Name] |

---

## Table of Contents

1. [Executive Summary](#1-executive-summary)
   - 1.1 [Trial Overview](#11-trial-overview)
   - 1.2 [Budget Summary](#12-budget-summary)
   - 1.3 [Key Financial Metrics](#13-key-financial-metrics)

2. [Budget Development](#2-budget-development)
   - 2.1 [Site Costs](#21-site-costs)
   - 2.2 [Vendor Costs](#22-vendor-costs)
   - 2.3 [Internal Resources](#23-internal-resources)
   - 2.4 [Contingency Planning](#24-contingency-planning)

3. [Payment Schedule](#3-payment-schedule)
   - 3.1 [Site Payment Terms](#31-site-payment-terms)
   - 3.2 [Vendor Payment Milestones](#32-vendor-payment-milestones)
   - 3.3 [Payment Tracking System](#33-payment-tracking-system)

4. [Financial Monitoring](#4-financial-monitoring)
   - 4.1 [Budget Tracking Methods](#41-budget-tracking-methods)
   - 4.2 [Variance Analysis](#42-variance-analysis)
   - 4.3 [Cost Control Measures](#43-cost-control-measures)
   - 4.4 [Financial Risk Management](#44-financial-risk-management)

5. [Reporting](#5-reporting)
   - 5.1 [Financial Status Reports](#51-financial-status-reports)
   - 5.2 [Accrual Tracking](#52-accrual-tracking)
   - 5.3 [Forecasting](#53-forecasting)

6. [Appendices](#6-appendices)
   - 6.1 [Budget Worksheet Templates](#61-budget-worksheet-templates)
   - 6.2 [Payment Tracking Templates](#62-payment-tracking-templates)
   - 6.3 [Financial Reporting Templates](#63-financial-reporting-templates)
   - 6.4 [References and Resources](#64-references-and-resources)

---

## 1. Executive Summary

### 1.1 Trial Overview

[Provide a brief overview of the clinical trial, including its purpose, design, and operational timeline. Include the following information:]

- Protocol Number: [Protocol Number]
- Study Title: [Study Title]
- Phase: [Phase]
- Indication: [Indication]
- Number of Sites: [Number] sites in [Number] countries
- Estimated Number of Subjects: [Number]
- Study Duration: [Duration] months
- First Patient First Visit (FPFV): [Date]
- Last Patient Last Visit (LPLV): [Date]
- Database Lock: [Date]
- Final Report: [Date]

### 1.2 Budget Summary

**Total Study Budget: [Currency] [Amount]**

| Budget Category | Amount | Percentage of Total |
|-----------------|--------|---------------------|
| Site Costs | [Currency] [Amount] | [Percentage]% |
| CRO/Vendor Costs | [Currency] [Amount] | [Percentage]% |
| Internal Resources | [Currency] [Amount] | [Percentage]% |
| Central Laboratory | [Currency] [Amount] | [Percentage]% |
| Clinical Supplies | [Currency] [Amount] | [Percentage]% |
| Travel and Meetings | [Currency] [Amount] | [Percentage]% |
| Regulatory Fees | [Currency] [Amount] | [Percentage]% |
| Data Management | [Currency] [Amount] | [Percentage]% |
| Contingency | [Currency] [Amount] | [Percentage]% |
| Other Costs | [Currency] [Amount] | [Percentage]% |
| **Total** | **[Currency] [Amount]** | **100%** |

### 1.3 Key Financial Metrics

| Metric | Target | Current Forecast |
|--------|--------|-----------------|
| Cost per Patient | [Currency] [Amount] | [Currency] [Amount] |
| Average Site Cost | [Currency] [Amount] | [Currency] [Amount] |
| Burn Rate (monthly) | [Currency] [Amount] | [Currency] [Amount] |
| Projected Budget Variance | ±[Percentage]% | [Percentage]% |
| Cost Performance Index (CPI) | >0.95 | [Value] |
| Schedule Performance Index (SPI) | >0.95 | [Value] |

[Add brief narrative explaining the financial metrics and any significant variances or considerations.]

---

## 2. Budget Development

### 2.1 Site Costs

#### 2.1.1 Site Budget Structure

| Cost Category | Description | Budgeting Methodology |
|---------------|-------------|------------------------|
| Startup Costs | Costs associated with site initiation, including regulatory submissions, contract negotiations, and site preparation | Fixed fee per site |
| Per-Patient Costs | Costs associated with screening, enrollment, treatment, and follow-up of each patient | Per-visit fee schedule based on procedures |
| Overhead Costs | Institutional overhead and administrative costs | Percentage of direct costs or negotiated rate |
| Closeout Costs | Costs associated with study closure activities | Fixed fee per site |

#### 2.1.2 Site Budget Template

[Include a brief description of the site budget template and how it should be used. The actual template will be included in Appendix 6.1.]

#### 2.1.3 Site Cost Assumptions

| Assumption | Value | Impact if Changed |
|------------|-------|------------------|
| Screen Failure Rate | [Percentage]% | [Impact of higher/lower rate] |
| Dropout Rate | [Percentage]% | [Impact of higher/lower rate] |
| Query Rate | [Number] per patient | [Impact of higher/lower rate] |
| Site Overhead Rate | [Percentage]% | [Impact of higher/lower rate] |
| Average Monitoring Visit Duration | [Number] hours | [Impact of longer/shorter visits] |
| [Other assumptions] | [Value] | [Impact] |

### 2.2 Vendor Costs

#### 2.2.1 Vendor Budget Summary

| Vendor Category | Services Provided | Budget | Payment Structure |
|-----------------|-------------------|--------|-------------------|
| CRO | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| Central Laboratory | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| Imaging Vendor | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| eCRF/EDC Provider | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| IRT Vendor | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| Drug Supply/Logistics | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| Data Management | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| Biostatistics | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |
| [Other vendors] | [List services] | [Currency] [Amount] | [Milestone-based/Fee for service/Hybrid] |

#### 2.2.2 Vendor Selection Financial Considerations

[Describe the financial considerations that went into vendor selection, including cost-effectiveness, payment terms, and contract structure.]

#### 2.2.3 Vendor Budget Assumptions

[List the key assumptions used in developing vendor budgets, including timelines, scope of work, and service level expectations.]

### 2.3 Internal Resources

#### 2.3.1 Personnel Budget

| Role | FTE Allocation | Duration (months) | Fully Loaded Cost/FTE/Year | Total Budget |
|------|----------------|-------------------|----------------------------|-------------|
| Project Manager | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| Clinical Research Associate | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| Medical Monitor | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| Data Manager | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| Biostatistician | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| Regulatory Affairs | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| Quality Assurance | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| [Other roles] | [Number] | [Number] | [Currency] [Amount] | [Currency] [Amount] |
| **Total** | | | | **[Currency] [Amount]** |

#### 2.3.2 Internal Cost Allocation

[Describe how internal costs are allocated to the study budget, including any cost-sharing arrangements or indirect cost calculations.]

#### 2.3.3 Resource Scheduling

[Describe how personnel resources are scheduled throughout the study timeline to optimize cost efficiency while maintaining quality and timelines.]

### 2.4 Contingency Planning

#### 2.4.1 Contingency Budget Allocation

| Risk Category | Contingency Amount | Percentage of Category Budget | Justification |
|---------------|--------------------|-----------------------------|---------------|
| Site-related Risks | [Currency] [Amount] | [Percentage]% | [Justification] |
| Enrollment Risks | [Currency] [Amount] | [Percentage]% | [Justification] |
| Vendor Performance Risks | [Currency] [Amount] | [Percentage]% | [Justification] |
| Protocol Amendment Risks | [Currency] [Amount] | [Percentage]% | [Justification] |
| Regulatory Risks | [Currency] [Amount] | [Percentage]% | [Justification] |
| [Other risk categories] | [Currency] [Amount] | [Percentage]% | [Justification] |
| **Total Contingency** | **[Currency] [Amount]** | **[Percentage]% of total budget** | |

#### 2.4.2 Contingency Release Process

[Describe the process for releasing contingency funds, including approval requirements and documentation.]

#### 2.4.3 Budget Amendment Process

[Outline the process for formally amending the study budget when changes exceed contingency or require reallocation between budget categories.]

---

## 3. Payment Schedule

### 3.1 Site Payment Terms

#### 3.1.1 Payment Structure

| Payment Type | Payment Trigger | Amount/Calculation | Timeline |
|--------------|-----------------|---------------------|----------|
| Site Initiation Payment | Site activation | [Currency] [Amount] or [Percentage]% of site budget | Within [Number] days of activation |
| Per-Patient Payments | Visit completion | Per visit schedule in Appendix 6.2 | [Monthly/Quarterly] within [Number] days of verified data |
| Screen Failure Payments | Screen failure documentation | [Currency] [Amount] per screen failure (up to [Number] per site) | [Monthly/Quarterly] within [Number] days of verified data |
| Unscheduled Visit Payments | Unscheduled visit documentation | [Currency] [Amount] per visit | [Monthly/Quarterly] within [Number] days of verified data |
| Close-out Payment | Site close-out visit completion | [Currency] [Amount] or [Percentage]% of site budget | Within [Number] days of close-out verification |
| Retention Bonus (if applicable) | [Percentage]% subject retention | [Currency] [Amount] | Study completion |

#### 3.1.2 Site Invoice Processing

[Describe the process for site invoice submission, review, and approval, including systems used and timelines.]

#### 3.1.3 Payment Holdbacks and Reconciliation

[Outline any payment holdbacks and the final reconciliation process at study completion.]

### 3.2 Vendor Payment Milestones

#### 3.2.1 Milestone Payment Schedule

| Vendor | Milestone | Percentage of Contract | Estimated Date | Amount |
|--------|-----------|------------------------|----------------|--------|
| CRO | Contract Execution | [Percentage]% | [Date] | [Currency] [Amount] |
| CRO | FPFV | [Percentage]% | [Date] | [Currency] [Amount] |
| CRO | [Percentage]% Enrollment | [Percentage]% | [Date] | [Currency] [Amount] |
| CRO | LPLV | [Percentage]% | [Date] | [Currency] [Amount] |
| CRO | Database Lock | [Percentage]% | [Date] | [Currency] [Amount] |
| CRO | Final Report | [Percentage]% | [Date] | [Currency] [Amount] |
| [Other vendors with similar milestone structure] | | | | |

#### 3.2.2 Performance-Based Payment Terms

[Describe any performance-based incentives or penalties in vendor contracts and how they impact payment schedules.]

#### 3.2.3 Vendor Invoice Review and Approval Process

[Outline the process for vendor invoice submission, review, approval, and payment, including responsible parties and timelines.]

### 3.3 Payment Tracking System

#### 3.3.1 Payment Tracking Tool

[Describe the payment tracking tool or system used to monitor all study-related payments, including key features and reports.]

#### 3.3.2 Accrual Tracking

[Explain how accrued costs are tracked and reported, particularly for work completed but not yet invoiced.]

#### 3.3.3 Payment Verification Process

[Detail the process for verifying that services or milestones have been completed before payment authorization.]

---

## 4. Financial Monitoring

### 4.1 Budget Tracking Methods

#### 4.1.1 Financial Management Systems

[Describe the systems and tools used to track and manage the study budget, including integration with other study management systems.]

#### 4.1.2 Budget vs. Actual Tracking

[Explain how budgeted costs are compared to actual expenditures, including frequency of review and reporting formats.]

#### 4.1.3 Commitment Tracking

[Describe how financial commitments (contracted but not yet expended) are tracked and incorporated into financial projections.]

### 4.2 Variance Analysis

#### 4.2.1 Variance Calculation Methodology

[Explain how budget variances are calculated and categorized (favorable or unfavorable).]

#### 4.2.2 Variance Investigation Thresholds

| Category | Threshold for Investigation | Action Required |
|----------|----------------------------|----------------|
| Site Costs | ±[Percentage]% or [Currency] [Amount] | [Action required] |
| Vendor Costs | ±[Percentage]% or [Currency] [Amount] | [Action required] |
| Internal Resources | ±[Percentage]% or [Currency] [Amount] | [Action required] |
| Overall Budget | ±[Percentage]% or [Currency] [Amount] | [Action required] |

#### 4.2.3 Variance Analysis Reporting

[Describe the format and frequency of variance analysis reporting, including required explanations for significant variances.]

### 4.3 Cost Control Measures

#### 4.3.1 Cost Containment Strategies

[List and describe the cost containment strategies implemented for the study, including their expected impact.]

#### 4.3.2 Approval Thresholds

| Expenditure Type | Approval Level 1 | Approval Level 2 | Approval Level 3 |
|------------------|------------------|------------------|------------------|
| Site Budget Changes | Up to [Currency] [Amount]: [Role] | [Currency] [Amount] to [Currency] [Amount]: [Role] | Over [Currency] [Amount]: [Role] |
| Vendor Change Orders | Up to [Currency] [Amount]: [Role] | [Currency] [Amount] to [Currency] [Amount]: [Role] | Over [Currency] [Amount]: [Role] |
| Resource Allocation Changes | Up to [Currency] [Amount]: [Role] | [Currency] [Amount] to [Currency] [Amount]: [Role] | Over [Currency] [Amount]: [Role] |
| Contingency Release | Up to [Currency] [Amount]: [Role] | [Currency] [Amount] to [Currency] [Amount]: [Role] | Over [Currency] [Amount]: [Role] |

#### 4.3.3 Cost Reduction Implementation

[Describe the process for implementing cost reduction measures when necessary, including assessment of impact on quality and timelines.]

### 4.4 Financial Risk Management

#### 4.4.1 Financial Risk Assessment

| Risk | Likelihood (1-5) | Impact (1-5) | Risk Score | Mitigation Strategy | Contingency Plan |
|------|------------------|--------------|------------|---------------------|------------------|
| Slow enrollment extending study timeline | [Score] | [Score] | [Score] | [Strategy] | [Plan] |
| Higher than expected screen failure rate | [Score] | [Score] | [Score] | [Strategy] | [Plan] |
| Currency exchange rate fluctuations | [Score] | [Score] | [Score] | [Strategy] | [Plan] |
| Vendor cost overruns | [Score] | [Score] | [Score] | [Strategy] | [Plan] |
| Protocol amendments requiring additional visits | [Score] | [Score] | [Score] | [Strategy] | [Plan] |
| [Other financial risks] | [Score] | [Score] | [Score] | [Strategy] | [Plan] |

#### 4.4.2 Financial Risk Monitoring

[Describe how financial risks are monitored throughout the study, including key indicators and review frequency.]

#### 4.4.3 Financial Risk Response Plan

[Outline the process for responding to realized financial risks, including escalation procedures and decision-making authority.]

---

## 5. Reporting

### 5.1 Financial Status Reports

#### 5.1.1 Report Types and Frequency

| Report Type | Content | Audience | Frequency | Creator | Approver |
|-------------|---------|----------|-----------|---------|----------|
| Executive Financial Summary | High-level budget vs. actual, forecast, key metrics | Executive Leadership | Monthly | [Role] | [Role] |
| Detailed Financial Report | Comprehensive budget vs. actual by category, variance analysis | Study Team, Finance | Monthly | [Role] | [Role] |
| Site Payment Report | Site-by-site payment tracking, projected payments | Site Management, Finance | Monthly | [Role] | [Role] |
| Vendor Payment Report | Vendor payments, milestone tracking, projected payments | Vendor Management, Finance | Monthly | [Role] | [Role] |
| Financial Risk Report | Current financial risks, mitigation status, potential impact | Study Team, Risk Management | Quarterly | [Role] | [Role] |

#### 5.1.2 Report Distribution

[Describe how financial reports are distributed, including systems used and security considerations.]

#### 5.1.3 Report Review Process

[Outline the process for reviewing financial reports, including meetings, action items, and follow-up requirements.]

### 5.2 Accrual Tracking

#### 5.2.1 Accrual Calculation Methodology

[Explain how accruals are calculated for different cost categories, including assumptions and estimation methods.]

#### 5.2.2 Accrual Reporting

[Describe how accruals are reported, including integration with financial statements and reconciliation processes.]

#### 5.2.3 Accrual Review and Adjustment

[Detail the process for reviewing and adjusting accruals, including frequency and responsible parties.]

### 5.3 Forecasting

#### 5.3.1 Forecasting Methodology

[Describe the methodology used for financial forecasting, including key drivers and assumptions.]

#### 5.3.2 Forecast Update Process

[Outline the process for updating forecasts, including frequency, triggers for off-cycle updates, and approval requirements.]

#### 5.3.3 Forecast Accuracy Tracking

[Explain how forecast accuracy is tracked and used to improve future forecasting.]

---

## 6. Appendices

### 6.1 Budget Worksheet Templates

#### 6.1.1 Site Budget Worksheet

```
[Example Site Budget Worksheet]

SITE BUDGET WORKSHEET
Site ID: _______
Investigator: _______
Currency: _______

STARTUP COSTS
IRB/EC Submission Fee:            _______
Site Initiation:                  _______
Regulatory Document Preparation:  _______
Training:                         _______
Other Startup Costs:              _______
Subtotal Startup:                 _______

PER-PATIENT COSTS
                          Procedure Cost  Time (hrs)  Total
Screening Visit:          _______        _______     _______
Randomization Visit:      _______        _______     _______
Treatment Visit 1:        _______        _______     _______
Treatment Visit 2:        _______        _______     _______
[Additional visits...]    _______        _______     _______
End of Study Visit:       _______        _______     _______
Subtotal Per-Patient:                               _______
x Expected # of Patients:                           _______
Total Patient Costs:                                _______

OVERHEAD/INDIRECT COSTS
Overhead Rate (%):                       _______
Overhead Amount:                         _______

CLOSEOUT COSTS
Site Closeout Visit:                     _______
Archive Preparation:                     _______
Other Closeout Costs:                    _______
Subtotal Closeout:                       _______

TOTAL SITE BUDGET:                       _______
```

#### 6.1.2 Study Budget Summary Template

```
[Example Study Budget Summary Template]

STUDY BUDGET SUMMARY
Protocol: _______
Date Prepared: _______
Currency: _______

SITE COSTS
Number of Sites:                  _______
Average Cost per Site:            _______
Total Site Costs:                 _______

VENDOR COSTS
CRO:                              _______
Central Laboratory:               _______
EDC:                              _______
IRT:                              _______
Drug Supply/Logistics:            _______
Other Vendor Costs:               _______
Total Vendor Costs:               _______

INTERNAL COSTS
Personnel (FTEs):                 _______
Travel and Meetings:              _______
Supplies and Equipment:           _______
Other Internal Costs:             _______
Total Internal Costs:             _______

REGULATORY FEES
IND/CTA Fees:                     _______
Ethics Committee Fees:            _______
Other Regulatory Costs:           _______
Total Regulatory Costs:           _______

CONTINGENCY
Contingency Amount:               _______
Contingency Percentage:           _______

TOTAL STUDY BUDGET:               _______
```

### 6.2 Payment Tracking Templates

#### 6.2.1 Site Payment Tracking Template

```
[Example Site Payment Tracking Template]

SITE PAYMENT TRACKING
Site ID: _______
Investigator: _______
Currency: _______

                        Amount Due    Invoice Date    Payment Date    Status
Startup Payment:        _______       _______         _______         _______

PATIENT 1
Screening Visit:        _______       _______         _______         _______
Randomization Visit:    _______       _______         _______         _______
Treatment Visit 1:      _______       _______         _______         _______
[Additional visits...]  _______       _______         _______         _______

PATIENT 2
Screening Visit:        _______       _______         _______         _______
[...]

Screen Failures:        _______       _______         _______         _______
Unscheduled Visits:     _______       _______         _______         _______
Closeout Payment:       _______       _______         _______         _______

TOTAL PAID TO DATE:     _______
TOTAL PENDING:          _______
TOTAL REMAINING:        _______
```

#### 6.2.2 Vendor Payment Tracking Template

```
[Example Vendor Payment Tracking Template]

VENDOR PAYMENT TRACKING
Vendor: _______
Contract Number: _______
Contract Value: _______
Currency: _______

Milestone               Due Amount    Invoice Date    Payment Date    Status
Contract Execution:     _______       _______         _______         _______
FPFV:                   _______       _______         _______         _______
25% Enrollment:         _______       _______         _______         _______
50% Enrollment:         _______       _______         _______         _______
75% Enrollment:         _______       _______         _______         _______
LPLV:                   _______       _______         _______         _______
Database Lock:          _______       _______         _______         _______
Final Report:           _______       _______         _______         _______

Pass-through Costs:     _______       _______         _______         _______

TOTAL PAID TO DATE:     _______
TOTAL PENDING:          _______
TOTAL REMAINING:        _______
```

### 6.3 Financial Reporting Templates

#### 6.3.1 Budget vs. Actual Report Template

```
[Example Budget vs. Actual Report Template]

BUDGET VS. ACTUAL REPORT
Protocol: _______
Reporting Period: _______
Currency: _______

Category           Budget      Actual      Variance    Variance %    Forecast    Comments
Site Costs:        _______     _______     _______     _______       _______     _______
CRO Costs:         _______     _______     _______     _______       _______     _______
Lab Costs:         _______     _______     _______     _______       _______     _______
Other Vendors:     _______     _______     _______     _______       _______     _______
Internal Resources: _______    _______     _______     _______       _______     _______
Travel:            _______     _______     _______     _______       _______     _______
Regulatory Fees:   _______     _______     _______     _______       _______     _______
Other Costs:       _______     _______     _______     _______       _______     _______

Subtotal:          _______     _______     _______     _______       _______     _______
Contingency:       _______     _______     _______     _______       _______     _______
TOTAL:             _______     _______     _______     _______       _______     _______

KEY METRICS
Burn Rate (Monthly): _______
Projected Completion: _______% of Budget
CPI: _______
SPI: _______
```

#### 6.3.2 Financial Forecast Template

```
[Example Financial Forecast Template]

FINANCIAL FORECAST
Protocol: _______
Forecast Date: _______
Currency: _______

                   Q1      Q2      Q3      Q4      Q1      Q2      Q3      Q4      Total
                   20XX    20XX    20XX    20XX    20XX    20XX    20XX    20XX

PLANNED BUDGET
Site Costs:        ____    ____    ____    ____    ____    ____    ____    ____    ____
CRO Costs:         ____    ____    ____    ____    ____    ____    ____    ____    ____
Other Vendors:     ____    ____    ____    ____    ____    ____    ____    ____    ____
Internal Costs:    ____    ____    ____    ____    ____    ____    ____    ____    ____
Other Costs:       ____    ____    ____    ____    ____    ____    ____    ____    ____
Subtotal:          ____    ____    ____    ____    ____    ____    ____    ____    ____

ACTUAL/FORECAST
Site Costs:        ____    ____    ____    ____    ____    ____    ____    ____    ____
CRO Costs:         ____    ____    ____    ____    ____    ____    ____    ____    ____
Other Vendors:     ____    ____    ____    ____    ____    ____    ____    ____    ____
Internal Costs:    ____    ____    ____    ____    ____    ____    ____    ____    ____
Other Costs:       ____    ____    ____    ____    ____    ____    ____    ____    ____
Subtotal:          ____    ____    ____    ____    ____    ____    ____    ____    ____

VARIANCE
Amount:            ____    ____    ____    ____    ____    ____    ____    ____    ____
Percentage:        ____    ____    ____    ____    ____    ____    ____    ____    ____
```

### 6.4 References and Resources

#### 6.4.1 Regulatory and Industry Guidelines

- [List relevant financial management guidelines and regulations]
- [Include references to industry standards for clinical trial budgeting]

#### 6.4.2 Internal Financial Policies and Procedures

- [List relevant organizational financial policies]
- [Include references to SOPs for financial management]

#### 6.4.3 Useful Resources

- [List helpful resources for clinical trial financial management]
- [Include links to professional organizations, publications, etc.]

---

## Implementation Notes

1. **Customization**: This template should be customized based on the specific requirements of each clinical trial, including study design, complexity, geographic scope, and organizational financial procedures.

2. **Budget Development**: Develop the budget with input from all key stakeholders, including clinical operations, data management, biostatistics, and finance.

3. **Risk-Based Approach**: Implement a risk-based approach to financial management, focusing resources on areas with the highest financial risks.

4. **Regular Updates**: Update the financial plan regularly as the study progresses and new information becomes available.

5. **Integration**: Ensure integration between financial management and other aspects of clinical trial management, including enrollment, site management, and timeline planning.

6. **Documentation**: Maintain clear documentation of all financial decisions, changes, and approvals throughout the study lifecycle.

7. **Compliance**: Ensure all financial processes comply with applicable regulations, accounting standards, and organizational policies.

8. **Stakeholder Communication**: Establish clear communication channels for financial information with all relevant stakeholders.

---

*Template Version: 1.0*
*Last Updated: [DATE]*
